Narrow-spectrum beta-lactam antibioticNARROW SPECTRUM

Phenoxymethylpenicillin (penicillin V)

Kåvepenin · Tikacillin · Fenoximetylpenicillin EQL Pharma

The first-choice oral penicillin for the most common respiratory and skin infections in outpatient care, and one of the reasons Sweden maintains a favourable resistance situation. The spectrum covers group A streptococci and pneumococci but not Haemophilus influenzae or staphylococci. Dosing differs substantially between indications — tonsillitis and acute otitis media are treated with different doses and durations, and this is a common source of error in practice.

BOXED WARNING

Anaphylaxis occurs, though rarely. Always ask about previous penicillin reactions and distinguish true type I allergy from childhood rashes occurring during infection — the majority of patients reporting penicillin allergy tolerate penicillin.

Dosing in adults

By indicationuppdaterad 2026-08-22
IndicationRegimenComment
Pharyngotonsillitis (Centor 3–4 + positive rapid strep test)1 g × 3 orally for 10 days; children 12,5 mg/kg × 3 for 10 daysdo not treat Centor 0–2 and do not test them either
Acute otitis mediaChildren 25 mg/kg × 3 orally for 5 days; adults 1,6 g × 3 for 5 days10 days for recurrence or complicating factors
Community-acquired pneumonia, CRB-65 0–11 g × 3 orally for 7 days2 g × 3 if weight exceeds 90 kg
Erysipelas1 g × 3 orally for 10 days2 g × 3 if weight exceeds 90 kg; 10–14 days if slow regression
Acute rhinosinusitis with treatment indication1,6 g × 3 orally for 7–10 daysmost sinusitis cases should not be treated with antibiotics
Renal impairment

No adjustment at eGFR above 30 ml/min. In severe renal impairment (eGFR below 30 ml/min) the dosing interval is extended or the daily dose reduced; risk of accumulation of the potassium salt in hyperkalaemia.

Hepatic impairment

No dose adjustment. Eliminated predominantly renally.

Children

12,5 mg/kg × 3 for pharyngotonsillitis and pneumonia, 25 mg/kg × 3 for acute otitis media and sinusitis. Maximum 1 g and 1,6 g per dose respectively. Available as oral suspension 50 and 100 mg/ml and as oral drops 250 mg/ml for the youngest children.

Pitfall

Wrong choice when Haemophilus influenzae or staphylococci are the likely pathogen: COPD exacerbation, sinusitis with treatment failure, wound infection, and impetigo are not covered by the spectrum. In tonsillitis with a Centor score of 0–2 neither a rapid test nor antibiotics should be used — the aetiology is viral.

Pharmacokinetics

BIOAVAIL.
approximately 50 % orally
approximately 30 minutes
PROTEIN BINDING
approximately 80 %
METABOLISM
Negligible
EXCRETION
Renal, tubular secretion
FOOD EFFECT
Absorption reduced by food
PK/PD INDEX
T > MIC — hence three-times-daily dosing
ONSET
Peak serum concentration after 30–60 minutes

Adverse effects by frequency

≥ 10 %
Loose stools, nausea, abdominal pain
1–10 %
Maculopapular exanthem, urticaria, eosinophilia, oral candidiasis
< 1 %
Anaphylaxis, Clostridioides difficile colitis, interstitial nephritis, haemolytic anaemia